You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
佐力藥業(300181.SZ)前三季度淨利潤預增106.13%-118.95%
格隆匯 07-27 20:14

格隆匯7月27日丨佐力藥業(300181.SZ)公佈,預計2021年前三季度歸屬於上市公司股東的淨利潤12856萬元-13656萬元,同比增長106.13%-118.95%;其中,第三季度歸屬於上市公司股東的淨利潤4200萬元-5000萬元,同比增長32.64%-57.91%。業績變動原因如下:

 1公司繼續堅持一體兩翼的戰略目標和穩自強、強招商的營銷策略,心產品烏靈系列、百令片保持銷售旺勢,主營業務收入去年同期較大增長同時中藥飲片業務努力拓展市場初見成效,中藥飲片系列產品主營業務收入年同期有所增長。隨着銷售量的增加,公司安排加大生產規模,產能利用率進一步提高,產品成本較去年同期顯著降低

2隨着公司營利水平及營利質量持續提升,公司的資金量更充裕,貸款規模有所降低,財務費用較去年同期顯著降低

320211-9月,預計非經常性損益對歸屬於上市公司股東的淨利潤的影響金額約470-570萬元

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account